Trial Search Results
Biomarkers for the Detection of Lymphatic Insufficiency
Acquired lymphedema is a disease that causes chronic swelling of the limb(s). It is frequently under-recognized or misdiagnosed. This study is designed to lead to the development of an accurate, noninvasive, blood test to allow testing for lymphedema. This approach is particularly useful to investigate relative responses to treatment interventions.
Stanford is currently accepting patients for this trial.
- Procedure: phlebotomy
- Other: Measurement of skin thickness by caliper
- Other: Limb volume quantitation by circumferential measurements
For lymphedema participants:
history of acquired lymphedema of at least 6 months' duration.
Control participants: no evidence of lymphedema, no lymph node dissection, no radiation
therapy, active inflammatory disease
active cancer, infection or bleeding tendency active coronary artery disease, congestive
heart failure history of stroke or TIA uncontrolled hypertension Renal insufficiency (serum
creatinine > 1.1) Active inflammatory or autoimmune disease (other than lymphedema)
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study